Answers are grounded in this paper and cite their sources.
Objective To determine whether relative thyroid-stimulating hormone (TSH)–free thyroxine (FT4) imbalance on postnatal day 2 was associated with subsequent TSH elevation in neonates admitted to a neonatal intensive care unit (NICU). Study Design This single-center retrospective cohort included 154 NICU-admitted neonates with simultaneous serum TSH, free triiodothyronine, and FT4 measurements on postnatal day 2 and at least one subsequent serum TSH measurement. The primary predictor was the TSH–FT4 Δ score, defined as cohort-standardized TSH minus cohort-standardized FT4. The primary outcome was new threshold crossing or a further TSH increase after day 2 using an operational threshold of >15 mIU/L. Associations were evaluated using Firth penalized logistic regression adjusted for gestational age. Results Eight infants met the primary outcome. Each 1-standard-deviation increase in the day-2 TSH–FT4 Δ score was associated with higher odds of subsequent TSH elevation (adjusted odds ratio, 2.47; 95% confidence interval, 1.13–5.91; p = 0.024). Day-2 TSH, day-2 FT4, and the TSH–FT4 average score showed no clear associations. A three-analyte score incorporating free triiodothyronine showed a similar association. Conclusion Relative TSH–FT4 discordance during early neonatal thyroid testing was associated with subsequent biochemical TSH elevation. These exploratory findings should not be interpreted as establishing a clinical predictive tool and require prospective external validation using standardized follow-up and clinically meaningful thyroid outcomes.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: